Clinical trial
Long Term Extension Trial of Setmelanotide
NCT03651765
Study timeline
Study start (actual)2018-07-15Date precision: day
Registry last updated2025-05-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
SetmelanotideDRUG · verified · RxNorm: setmelanotide
Sponsors & collaborators
Rhythm Pharmaceuticals, Inc.lead sponsor
Mapped research locations
ParisFrance2PhiladelphiaPennsylvania, United States1NashvilleTennessee, United States1MadridSpain1LondonUnited Kingdom1SeattleWashington, United States1San DiegoCalifornia, United States1BerlinGermany1DurhamNorth Carolina, United States1BuffaloNew York, United States1EdmontonAlberta, Canada1GainesvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03651765 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.